资讯

MassDevice7 小时
Abbott has positive study results for Aveir CSP leadless pacemaker
Abbott (NYSE: ABT) today announced data from an acute clinical feasibility study of its Aveir Conduction System Pacing (CSP) ...
Le Lézard8 小时
Abbott Highlights New AVEIRtm Data, Initiates Trial for the Company's Conduction System ...
Abbott today announced late-breaking data from the AVEIRtm Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the investigational AVEIR ...
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System ...
Abbott (NYSE: ABT) today announced late-breaking data from the AVEIR™ Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the ...